Speakers

Mr. Jones is the Chief Commercial Officer for Nanoform Finland Plc and a member of the Management Team. He oversees all commercial activities for the company and leads a strong and talented sales, marketing and business intelligence team across US and Europe. Since joining Nanoform at the end of 2018 the company has grown from 18 to approximately 150 people, established commercial relationships with 10 of the top 20 pharma and biotech companies globally, become a listed public company on NASDAQ First North Premier in Finland and Sweden and raised approximately 150m Euros to support the technology development and commercialization in Europe and US.

Prior to joining Nanoform he has served as Commercial Director, Innovator Pharma Products and Solutions at Johnson Matthey Plc and was a member of the Senior Leadership Team for the Global Health Sector. Prior to this he was Head of Asia Pacific Sales and member of the Senior Leadership Team at Dr. Reddy’s Global Custom Pharma Solutions business after holding the roles of Associate Director and Manager of Sales and Business Development, Europe. His first commercial role was at Prosonix Ltd, where he led global business development for their proprietary particle engineering technology. Prosonix was later sold to Circassia for £100M.

Mr Jones has extensive experience in understanding the value between Drug Substance and Drug Product development and the critical importance particle engineering and solid form can play to deliver value for patients.

Presentation Title: Nanoforming - the Patient and Planet Centric Approach From Increasing Bioavailability to Enabling Sustained Drug Delivery

Abstract: Nanoform are working with many companies globally to address the pressing issue of drug bioavailability. Listen to this talk to understand how nanoparticles made by the green CESS technology can help to solve this hurdle and at the same time deliver more patient centric medicines.

This talk will also cover a new proprietary formulation platform developed by Nanoform that acts as part of the Nanoforming toolbox to increase flexibility for processing some challenging molecules. Nanoform can now change the solid state properties of nanoparticles post processing, controlling a solid state change from nanoamorphous to nanocrystalline without changing the particle size. Listen in to see how Nanoform have developed a green viable alternative to ASDs and Spray Drying, without the need for organic hydrocarbon solvents and high polymer loads.

This talk will also cover recent work conducted with Celanese where nanoparticles have been used to create high drug load long acting sustained release implants.

Small really is a powerful ingredient in formulation!

View company profile